Bates Sandra R, Kazi Altaf S, Tao Jian-Qin, Yu Kevin J, Gonder Daniel S, Feinstein Sheldon I, Fisher Aron B
Institute for Environmental Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
Am J Physiol Lung Cell Mol Physiol. 2008 Oct;295(4):L658-69. doi: 10.1152/ajplung.90233.2008. Epub 2008 Aug 15.
We have recently described a putative receptor for lung surfactant protein-A (SP-A) on rat type II pneumocytes. The receptor, P63, is a 63-kDa type II transmembrane protein. Coincubation of type II cells with P63 antibody (Ab) reversed the inhibitory effect of SP-A on secretagogue-stimulated surfactant secretion from type II cells. To further characterize SP-A interactions with P63, we expressed recombinant P63 protein in Escherichia coli and generated antibodies to P63. Immunogold electron microscopy confirmed endoplasmic reticulum and plasma membrane localization of P63 in type II cells with prominent labeling of microvilli. Binding characteristics of iodinated SP-A to type II cells in the presence of P63 Ab were determined. Binding (4 degrees C, 1 h) of (125)I-SP-A to type II cells demonstrated both specific (calcium-dependent) and nonspecific (calcium-independent) components. Ab to P63 protein blocked the specific binding of (125)I-SP-A to type II cells and did not change the nonspecific SP-A association. A549 cells, a pneumocyte model cell line, expressed substantial levels of P63 and demonstrated specific binding of (125)I-SP-A that was inhibited by the P63 Ab. The secretagogue (cAMP)-stimulated increase in calcium-dependent binding of SP-A to type II cells was blocked by the presence of P63 Ab. Transfection of type II cells with small interfering RNA to P63 reduced P63 protein expression, attenuated P63-specific SP-A binding, and reversed the ability of SP-A to prevent surfactant secretion from the cells. Our results further substantiate the role of P63 as an SP-A receptor protein localized on the surface of lung type II cells.
我们最近描述了大鼠II型肺泡上皮细胞上一种假定的肺表面活性物质蛋白A(SP-A)受体。该受体P63是一种63 kDa的II型跨膜蛋白。II型细胞与P63抗体(Ab)共同孵育可逆转SP-A对促分泌剂刺激的II型细胞表面活性物质分泌的抑制作用。为了进一步表征SP-A与P63的相互作用,我们在大肠杆菌中表达了重组P63蛋白并制备了针对P63的抗体。免疫金电子显微镜证实了II型细胞中P63在内质网和质膜的定位,微绒毛有明显标记。测定了在P63 Ab存在下碘化SP-A与II型细胞的结合特性。(125)I-SP-A在4℃下与II型细胞结合1小时,显示出特异性(钙依赖性)和非特异性(钙非依赖性)成分。P63蛋白抗体阻断了(125)I-SP-A与II型细胞的特异性结合,且未改变非特异性SP-A结合。A549细胞,一种肺上皮细胞模型细胞系,表达大量P63,并显示出(125)I-SP-A的特异性结合,该结合被P63 Ab抑制。促分泌剂(cAMP)刺激的SP-A与II型细胞钙依赖性结合的增加被P63 Ab的存在所阻断。用针对P63的小干扰RNA转染II型细胞可降低P63蛋白表达,减弱P63特异性SP-A结合,并逆转SP-A阻止细胞表面活性物质分泌的能力。我们的结果进一步证实了P63作为一种位于肺II型细胞表面的SP-A受体蛋白的作用。